CY Molecular Diagnostics (CYMD)

CY Molecular Diagnostics (CYMD) is a biotechnology startup with the slogan "Companion Diagnostics for Precision Medicine in Oncology". Founded in 2015, the company focuses on Companion Diagnostics (CDx) for oncology precision medicine, utilizing state-of-the-art technology to provide result-driven services. CYMD aims to make molecular testing convenient and affordable while offering direct access to testing anywhere and anytime. The company recently received a Seed Round investment at 03 March 2023 from the San Diego Angel Conference. This indicates a promising future for CYMD, as it secures funding and support from a reputable investor. Being headquartered in the United States, the company is positioned within a hub of innovation and biotech expertise. Overall, CY Molecular Diagnostics appears to be well-positioned in the biotechnology industry, with a clear focus on precision medicine for oncology. The recent investment is a positive signal of confidence from the San Diego Angel Conference, potentially paving the way for further growth and advancement in the field of molecular diagnostics.